Tecvayli Injection
Product Images NDC 57894-449

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tecvayli (NDC 57894-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (30 mg/3 mL Vial Carton)

Principal Display Panel (30 mg/3 mL Vial Carton)
TECVAYLI™ is an injection medicine containing 30 mg of teclistamab-cqyv in each single-dose vial. The vial also contains edetate disodium, glacial acetic acid, polysorbate 20, sodium scetate, sucrose, and water for injection with no preservatives. The recommended dosage should be obtained from the prescribing information. This medication should be stored in the refrigerator at 2°C to 8°C and protected from light, and it should not be frozen. TECVAYLI™ is for subcutaneous injection by a healthcare professional only. Unused portions should be discarded. Mixing vials of different concentrations should not be done to achieve a treatment dose.*
FDA Label Image

Principal Display Panel (153 mg/1.7 mL Vial Carton)

Principal Display Panel (153 mg/1.7 mL Vial Carton)
This is a description of TECVAYLI, an injection for subcutaneous use manufactured in Ireland by Janssen Biotech, Inc. Each single-dose vial contains 153mg of teclistamab-cayy, along with other ingredients such as sucrose and water for injection. The recommended dosage information is not provided, but the prescribing information should be consulted. The vials should be stored refrigerated and discarded if unused. It is important to note that TECVAYLI vials of different concentrations should not be combined. The medication guide should be provided to each patient by the healthcare provider. Patent information is also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.